drugset / Trial / NCT01018225
Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
Summary
The purpose of this study is to evaluate the efficacy of darifenacin in the treatment of moderate to severe nocturia in patients with overactive bladder and who do not have non-urologic causes of nocturia.
Timeline
- Start
- 2009-11
- Primary completion
- —
- Completion
- 2010-07
Outcome
Outcome not reported
Stopped (Enrollment): “Study was cancelled due to lack of enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darifenacin | Small molecule | 7.5 mg | — |
| Subject | Darifenacin | Small molecule | 15 mg | — |
Indications
No indication recorded.